Otros idiomas Pacific Shuanglin Bio-pharmacy Co., LTD

Acciones

000403

CNE000000F14

Precio de cierre Shenzhen S.E. Otros sitios de cotización 00:00:00 30/04/2024			Varia. Cinco días.	Varia. 1 de enero.
29,29 ^CNY	-1,61 %		-1,94 %	+7,53 %

26/04	Pacific Shuanglin Bio-pharmacy Co., LTD informa de los resultados de beneficios del primer trimestre finalizado el 31 de marzo de 2024	CI
15/04	El beneficio de Pacific Shuanglin Bio-pharmacy en 2023 aumenta un 4% a pesar de los menores ingresos; las acciones suben un 4	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Pacific Shuanglin Bio-pharmacy Co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04
Pacific Shuanglin Bio-pharmacy's 2023 Profit Jumps 4% Despite Lower Revenue; Shares Rise 4%	15/04
Pacific Shuanglin Bio-pharmacy's Profit Seen More Than Doubling in Q1; Shares Up 3%	15/04
Pacific Shuanglin Bio-pharmacy Co., LTD Reports Earnings Results for the Full Year Ended December 31, 2023	12/04
Pacific Shuanglin Bio-pharmacy Co., LTD announced a financing transaction	23/02
Pacific Shuanglin Bio-pharmacy Unit Gets Nod to Trial Human Coagulation Factor IX	06/11
Pacific Shuanglin Bio-pharmacy Co., LTD Approves Board Appointments	26/10/23
Pacific Shuanglin Bio-pharmacy Co., LTD Reports Earnings Results for the Nine Months Ended September 30, 2023	18/10/23
Pacific Shuanglin Bio-pharmacy Obtains Another Blood Collection License	22/09/23
Pacific Shuanglin Bio-pharmacy Co., LTD Reports Earnings Results for the Half Year Ended June 30, 2023	23/08/23
Pacific Shuanglin Bio-pharmacy Obtains Blood Plasma Collection License	08/08/23
Tranche Update on Pacific Shuanglin Bio-pharmacy Co., LTD's Equity Buyback Plan announced on September 1, 2022.	21/07/23
Pacific Shuanglin Bio-pharmacy Co., LTD's Equity Buyback announced on September 1, 2022 has expired with 1,968,378 shares, representing 0.27% for CNY 40.1 million.	20/07/23
Pacific Shuanglin Bio-Pharmacy Co., Ltd Announces Final Dividend Implementation on A Shares for the Year 2022, Payable on July 20, 2023	14/07/23
Tranche Update on Pacific Shuanglin Bio-pharmacy Co., LTD's Equity Buyback Plan announced on September 1, 2022.	03/07/23
Pacific Shuanglin Bio-pharmacy's Unit Gets Permit to Operate Two Plasma Hubs	26/05/23
Pacific Shuanglin Bio-Pharmacy Co., Ltd Approves 2022 Profit Distribution Plan	23/05/23
Gongqingcheng Shengbang Yinghao Investment Partnership (Limited Partnership) completed the acquisition of 20.99% stake in Pacific Shuanglin Bio-pharmacy Co., LTD from Hangzhou Zhemintou Tianhong Investment Partnership Enterprise (LP) and Zhejiang Private Enterprise United Investment Co., Ltd.	23/05/23
Pacific Shuanglin Bio-pharmacy Registers Blood Clotting Drug	18/05/23
Pacific Shuanglin Bio-pharmacy Signs Drug Supply, Distribution Deal With Brazil’s Hypera Pharma	05/05/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Pacific Shuanglin Bio-pharmacy Co., LTD

Acciones

000403

CNE000000F14

Otros idiomas

Filtros